Additional Transcription Factor Compounds: Small Molecules and Peptides
18 results for "Additional Transcription Factor Compounds Small Molecules and Peptides" in Products
18 results for "Additional Transcription Factor Compounds Small Molecules and Peptides" in Products
Additional Transcription Factor Compounds: Small Molecules and Peptides
GLI antagonist; inhibits Hedgehog (Hh) signaling
| Chemical Name: | 2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine |
| Purity: | ≥98% (HPLC) |
YAP inhibitor
| Alternate Names: | Visudyne |
| Chemical Name: | (4R,4aS)-18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-24H,26H-benzo[b]porphine-9,13-dipropanoic acid monomethyl ester |
| Purity: | ≥95% (HPLC) |
Core binding factor inhibitor; attenuates hematopoiesis
| Alternate Names: | CBFβ-Runx1 inhibitor II |
| Chemical Name: | 7-Chloro-1,3-dihydro-5-(1H-pyrrol-2-yl)-2H-1,4-benzodiazepin-2-one |
| Purity: | ≥98% (HPLC) |
Potent and selective CREB inhibitor
| Chemical Name: | 3-(3-Aminopropoxy)-N-[2-[[3-[[(4-chloro-2-hydroxyphenyl)amino]carbonyl]-2-naphthalenyl]oxy]ethyl]-2-naphthalenecarboxamide hydrochloride |
| Purity: | ≥98% (HPLC) |
Hepatocyte nuclear factor 4α (HNF4α) antagonist
| Chemical Name: | 2-Methyl-1-[(2-methyl-5-nitrophenyl)sulfonyl]-1H-benzimidazole |
| Purity: | ≥98% (HPLC) |
Brachyury down modulator
| Chemical Name: | (E)-4-(Dimethylamino)-N-[1-[4-fluoro-3-(2,2,2-trifluoroethoxy)anilino]-6-methoxy-7-isoquinolyl]but-2-enamide |
| Purity: | ≥98% (HPLC) |
Cryptochrome protein stabilizer; lengthens circadian period
| Chemical Name: | N-[3-(9H-Carbazol-9-yl)-2-hydroxypropyl]-N-(2-furanylmethyl)methanesulfonamide |
| Purity: | ≥98% (HPLC) |
Selective Smad3 inhibitor; inhibits TGF-βR1 signaling
| Chemical Name: | 1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[(2E)-3-(1-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1-oxo-2-propenyl]-isoquinoline hydrochloride |
| Purity: | ≥97% (HPLC) |
TRIM24 Degrader (PROTAC®)
| Chemical Name: | (2S,4R)-1-((S)-15-(tert-Butyl)-1-(3-(N-(1,3-dimethyl-2-oxo-6-(3-propoxyphenoxy)-2,3-dihydro-1H-benzo[d]imidazol-5-yl)sulfamoyl)phenyl)-1,13-dioxo-5,8,11-trioxa-2,14-diazahexadecan-16-oyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide |
| Purity: | ≥98% (HPLC) |
Inhibits c-Myc-Max dimerization
| Chemical Name: | 5-[(4-Ethylphenyl)methylene]-2-thioxo-4-thiazolidinone |
| Purity: | ≥98% (HPLC) |
Potent pan-TEAD inhibitor
| Chemical Name: | N-[(1S)-1-(2-Pyridinyl)ethyl]-5-[4-(trifluoromethyl)phenyl]-2-naphthalenecarboxamide |
| Purity: | ≥98% (HPLC) |
Potent and reversible inhibitor of TEAD mediated Hippo/Yap signalling
| Chemical Name: | 4-[3-(2-Cyclohexylethoxy)benzoyl]-N-phenyl-1-piperazinecarboxamide |
| Purity: | ≥98% (HPLC) |
Potent and selective Foxo1 inhibitor; orally bioavailable
| Chemical Name: | 5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid |
| Purity: | ≥98% (HPLC) |
High affinity Nur77 agonist
| Chemical Name: | Ethyl 3,5-dihydroxy-2-(1-oxooctyl)-benzeneacetate |
| Purity: | ≥98% (HPLC) |
High affinity Myc inhibitor
| Chemical Name: | 4-[2-(2-Furanyl)-6-(4-nitrophenyl)-4-pyridinyl]benzamide |
| Purity: | ≥98% (HPLC) |
Steroid receptor coactivator 3 (SRC-3) inhibitor
| Chemical Name: | 1-(2-Pyridinyl)ethanone 2-(1-methyl-1H-benzimidazol-2-yl)hydrazone hydrochloride |
| Purity: | ≥98% (HPLC) |
Selective inhibitor of ATF6α; sensitizes cells to ER stress
| Chemical Name: | N-[1-[[2,4-bis(Trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-5-(2-furanyl)-3-isoxazolecarboxamide |
| Purity: | ≥98% (HPLC) |
YAP inhibitor
| Purity: | ≥95% (HPLC) |
